Ligand |
|
|
|
|
|
|
|
|
|
|
|
[3H]NLX-112
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.9
|
pKd
|
34
|
|
⤷ |
pKd
8.9
(Kd 1.4x10-9 M)
[34]
|
[3H]8-OH-DPAT
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.0 – 9.4
|
pKd
|
9,40,70,73
|
|
⤷ |
pKd
6.0 – 9.4
(Kd 1x10-6 – 3.98x10-10 M)
[9,40,70,73]
|
[3H]S-15535
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
5.8 – 5.9
|
pKd
|
73
|
|
⤷ |
pKd
5.8 – 5.9
[73]
|
S-14671
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
10.2 – 10.5
|
pKi
|
71,73
|
|
⤷ |
pKi
10.2 – 10.5
[71,73]
|
LY293284
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
10.1
|
pKi
|
9
|
|
⤷ |
pKi
10.1
[9]
|
5-CT
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.4 – 10.3
|
pKi
|
69,71,73-74
|
|
⤷ |
pKi
9.4 – 10.3
[69,71,73-74]
|
lisuride
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.7 – 9.8
|
pKi
|
61,61,73
|
|
⤷ |
pKi
9.7 – 9.8
[61,61,73]
|
U92016A
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.7
|
pKi
|
58
|
|
⤷ |
pKi
9.7
[58]
|
vilazodone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
9.7
|
pKi
|
19
|
|
⤷ |
pKi
9.7
(Ki 2x10-10 M)
[19]
Description: Binding of vilazodone to human 5-HT1A receptors against [3H]8-OH-DPAT (DPAT)
|
S-14506
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.6 – 9.7
|
pKi
|
71,73
|
|
⤷ |
pKi
9.6 – 9.7
[71,73]
|
roxindole
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
9.4 – 9.9
|
pKi
|
61,70
|
|
⤷ |
pKi
9.4 – 9.9
[61,70]
|
5-hydroxytryptamine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.1 – 9.7
|
pKi
|
40,69-71,73-74
|
|
⤷ |
pKi
9.1 – 9.7
[40,69-71,73-74]
|
flesinoxan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.3
|
pKi
|
71
|
|
⤷ |
pKi
9.3
[71]
|
L-694,247
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.3
|
pKi
|
69
|
|
⤷ |
pKi
9.3
[69]
|
S-15535
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
9.2
|
pKi
|
73
|
|
⤷ |
pKi
9.2
[73]
|
Lysergide
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.0
|
pKi
|
75
|
|
⤷ |
pKi
9.0
[75]
|
RU 24969
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
9.0
|
pKi
|
71
|
|
⤷ |
pKi
9.0
[71]
|
flibanserin
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
9.0
|
pKi
|
10
|
|
⤷ |
pKi
9.0
(Ki 1x10-9 M)
[10]
|
8-OH-DPAT
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.4 – 9.4
|
pKi
|
20,30,40,62,71,73,73-74
|
|
⤷ |
pKi
8.4 – 9.4
(Ki 3.98x10-9 – 3.98x10-10 M)
[20,30,40,62,71,73,73-74]
|
LY 165,163
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.9
|
pKi
|
71
|
|
⤷ |
pKi
8.9
[71]
|
spiroxatrine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.8
|
pKi
|
71
|
|
⤷ |
pKi
8.8
[71]
|
ipsapirone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.6 – 8.8
|
pKi
|
71,73
|
|
⤷ |
pKi
8.6 – 8.8
[71,73]
|
FG-5893
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.7
|
pKi
|
71
|
|
⤷ |
pKi
8.7
[71]
|
pergolide
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.7
|
pKi
|
61
|
|
⤷ |
pKi
8.7
[61]
|
7-methoxy-1-naphthylpiperazine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.6
|
pKi
|
39
|
|
⤷ |
pKi
8.6
[39]
|
(R)-UH 301
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.6
|
pKi
|
71
|
|
⤷ |
pKi
8.6
(Ki 2.74x10-9 M)
[71]
|
NLX-101
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.6
|
pKi
|
72
|
|
⤷ |
pKi
8.6
[72]
|
terguride
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.5
|
pKi
|
61
|
|
⤷ |
pKi
8.5
[61]
|
ziprasidone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.9 – 8.9
|
pKi
|
71,92
|
|
⤷ |
pKi
7.9 – 8.9
[71,92]
|
S 16924
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.4
|
pKi
|
59
|
|
⤷ |
pKi
8.4
[59]
|
aripiprazole
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
8.2
|
pKi
|
95
|
|
⤷ |
pKi
8.2
[95]
|
tandospirone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.2
|
pKi
|
71
|
|
⤷ |
pKi
8.2
[71]
|
lurasidone
|
|
|
|
|
|
|
|
|
|
|
Rn |
Partial agonist |
8.2
|
pKi
|
35
|
|
⤷ |
pKi
8.2
(Ki 6.75x10-9 M)
[35]
|
asenapine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.0 – 8.3
|
pKi
|
71,92
|
|
⤷ |
pKi
8.0 – 8.3
[71,92]
|
zalospirone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.1
|
pKi
|
71
|
|
⤷ |
pKi
8.1
[71]
|
1-naphthylpiperazine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.0
|
pKi
|
39
|
|
⤷ |
pKi
8.0
[39]
|
ocaperidone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
8.0
|
pKi
|
27
|
|
⤷ |
pKi
8.0
[27]
|
bromocriptine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.9
|
pKi
|
61
|
|
⤷ |
pKi
7.9
[61]
|
buspirone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.7 – 8.0
|
pKi
|
71,73-74
|
|
⤷ |
pKi
7.7 – 8.0
[71,73-74]
|
vortioxetine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.8
|
pKi
|
7
|
|
⤷ |
pKi
7.8
(Ki 1.5x10-8 M)
[7]
|
LY334370
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.8
|
pKi
|
99
|
|
⤷ |
pKi
7.8
[99]
|
BRL-15572
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.7
|
pKi
|
85
|
|
⤷ |
pKi
7.7
[85]
|
cabergoline
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.7
|
pKi
|
61
|
|
⤷ |
pKi
7.7
[61]
|
donitriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.6
|
pKi
|
38
|
|
⤷ |
pKi
7.6
[38]
|
eletriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.4
|
pKi
|
68
|
|
⤷ |
pKi
7.4
[68]
|
naratriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.1 – 7.6
|
pKi
|
68-69
|
|
⤷ |
pKi
7.1 – 7.6
[68-69]
|
nafadotride
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.3
|
pKi
|
71
|
|
⤷ |
pKi
7.3
[71]
|
LP-44
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
7.3
|
pKi
|
52
|
|
⤷ |
pKi
7.3
(Ki 5.27x10-8 M)
[52]
|
frovatriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
7.2
|
pKi
|
103
|
|
⤷ |
pKi
7.2
(Ki 6x10-8 M)
[103]
|
LP-12
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
7.2
|
pKi
|
52
|
|
⤷ |
pKi
7.2
(Ki 6.09x10-8 M)
[52]
|
BMY-14802
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.2
|
pKi
|
71
|
|
⤷ |
pKi
7.2
[71]
|
xanomeline
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.2
|
pKi
|
101
|
|
⤷ |
pKi
7.2
[101]
|
avitriptan
|
|
|
|
|
|
|
|
|
|
|
Rn |
Agonist |
7.2
|
pKi
|
91
|
|
⤷ |
pKi
7.2
(Ki 7.08x10-8 M)
[91]
|
GR 127935
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
7.1 – 7.2
|
pKi
|
39,85
|
|
⤷ |
pKi
7.1 – 7.2
[39,85]
|
apomorphine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.9
|
pKi
|
61
|
|
⤷ |
pKi
6.9
[61]
|
clozapine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.8 – 6.9
|
pKi
|
59,71,92
|
|
⤷ |
pKi
6.8 – 6.9
[59,71,92]
|
EMDT
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.8
|
pKi
|
29
|
|
⤷ |
pKi
6.8
[29]
|
fluparoxan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.8
|
pKi
|
62
|
|
⤷ |
pKi
6.8
[62]
|
LP-211
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
6.7
|
pKi
|
53
|
|
⤷ |
pKi
6.7
(Ki 1.88x10-7 M)
[53]
|
zolmitriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.6
|
pKi
|
68
|
|
⤷ |
pKi
6.6
[68]
|
quetiapine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.5 – 6.6
|
pKi
|
71,92
|
|
⤷ |
pKi
6.5 – 6.6
[71,92]
|
piribedil
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.4
|
pKi
|
61
|
|
⤷ |
pKi
6.4
[61]
|
rizatriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.4
|
pKi
|
68
|
|
⤷ |
pKi
6.4
[68]
|
LY344864
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.3
|
pKi
|
81
|
|
⤷ |
pKi
6.3
[81]
|
SB 216641
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.3
|
pKi
|
85
|
|
⤷ |
pKi
6.3
[85]
|
CP 93129
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.1
|
pKi
|
69
|
|
⤷ |
pKi
6.1
[69]
|
capeserod
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.0
|
pKi
|
65
|
|
⤷ |
pKi
6.0
[65]
|
sumatriptan
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
6.0
|
pKi
|
68
|
|
⤷ |
pKi
6.0
[68]
|
quinpirole
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
5.8
|
pKi
|
70
|
|
⤷ |
pKi
5.8
[70]
|
olanzapine
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
5.6 – 5.8
|
pKi
|
71,92
|
|
⤷ |
pKi
5.6 – 5.8
[71,92]
|
vilazodone
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
9.5
|
pIC50
|
32
|
|
⤷ |
pIC50
9.5
(IC50 3x10-10 M)
[32]
|
BMY-7378
|
|
|
|
|
|
|
|
|
|
|
Hs |
Partial agonist |
6.8 – 8.0
|
pIC50
|
43
|
|
⤷ |
pIC50
6.8 – 8.0
[43]
|
L-772,405
|
|
|
|
|
|
|
|
|
|
|
Hs |
Full agonist |
7.2
|
pIC50
|
89
|
|
⤷ |
pIC50
7.2
[89]
|
ulotaront
|
|
|
|
|
|
|
|
|
|
|
Hs |
Agonist |
5.6
|
pIC50
|
21
|
|
⤷ |
pIC50
5.6
(IC50 2.3x10-6 M)
[21]
|
|